Targeting the untargeted in molecular phenomics with structurally-selective ion mobility-mass spectrometry

Current Opinion in Biotechnology

Volumn 39, Issue , 2016, Pages 192-197

  May, Jody Christopher ^a   Gant Branum, Randi Lee ^a   McLean, John Allen ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; DRUG PRODUCTS; MASS SPECTROMETRY; SCALES (WEIGHING INSTRUMENTS); SPECTROMETRY;

DATA DIMENSIONALITY; DATA PROJECTION; DISCOVERY SCIENCE; ION MOBILITY-MASS SPECTROMETRY; SIZE AND SHAPE; STATISTICAL TECHNIQUES; SYNTHETIC BIOLOGY; TECHNOLOGICAL ADVANCES;

BIG DATA;

ANALYTIC METHOD; BIOINFORMATICS; CONTROLLED STUDY; DATA DENSITY; DATA DIMENSIONALITY; DATA INTERROGATION; DATA PROCESSING; DATA PROJECTION; HUMAN; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; MOLECULAR BIOLOGY; MOLECULAR PHENOMICS; MOLECULAR PHENOTYPE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPRODUCIBILITY; REVIEW; SEPARATION TECHNIQUE; STRUCTURAL SEPARATION; STRUCTURALLY SELECTIVE ION MOBILITY MASS SPECTROMETRY; SYNTHETIC BIOLOGY; WORKFLOW; ANIMAL; BIOLOGY; CELL FUNCTION; DRUG DEVELOPMENT; PROCEDURES;

ANIMALS; CELL PHYSIOLOGICAL PHENOMENA; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; HUMANS; MASS SPECTROMETRY; PHENOTYPE;

EID: 84964413107     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2016.04.013     Document Type: Review

References (52)

1. Hood L., Heath J.R., Phelps M.E., Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306:640-643.
2. Flores M., Glusman G., Brogaard K., Price N.D., Hood L. P4 medicine: how systems medicine will transform the healthcare sector and society. Per Med 2013, 10:565-576.
3. Ideker T., Thorsson V., Ranish J.A., Christmas R., Buhler J., Eng J.K., Bumgarner R., Goodlett D.R., Aebersold R., Hood L. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001, 292:929-934.
4. Roden D.M., Pulley J.M., Basford M.A., Bernard G.R., Clayton E.W., Balser J.R., Masys D.R. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 2008, 84:362-369.
5. Ritchie M.D., Denny J.C., Crawford D.C., Ramirez A.H., Weiner J.B., Pulley J.M., Basford M.A., Brown-Gentry K., Balser J.R., Masys D.R., et al. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet 2010, 86:560-572.
6. Denny J.C., Ritchie M.D., Basford M.A., Pulley J.M., Bastarache L., Brown-Gentry K., Wang D., Masys D.R., Roden D.M., Crawford D.C. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 2010, 26:1205-1210.
7. Patti G.J., Yanes O., Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012, 13:263-269.
8. Fuhrer T., Zamboni N. High-throughput discovery metabolomics. Curr Opin Biotechnol 2015, 31:73-78.
9. May J.C., Goodwin C.R., McLean J.A. Ion mobility-mass spectrometry strategies for untargeted systems, synthetic, and chemical biology. Curr Opin Biotechnol 2015, 31:117-121.
10. Holmes E., Wijeyesekera A., Taylor-Robinson S.D., Nicholson J.K. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2015, 12:458-471.
11. Nicholson J.K., Holmes E., Kinross J.M., Darzi A.W., Takats Z., Lindon J.C. Metabolic phenotyping in clinical and surgical environments. Nature 2012, 491:384-392.
12. Holmes E., Loo R.L., Stamler J., Bictash M., Yap I.K., Chan Q., Ebbels T., De Iorio M., Brown I.J., Veselkov K.A., Daviglus M.L., Kesteloot H., Ueshima H., Zhao L., Nicholson J.K., Elliott P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453:396-400.
13. Bowton E.A., Collier S.P., Wang X., Sutcliffe C.B., Van Driest S.L., Couch L.J., Herrera M., Jerome R.N., Slebos R.J., Alborn W.E., Liebler D.C., McNaughton C.D., Mernaugh R.L., Wells Q.S., Brown N.J., Roden D.M., Pulley J.M. Phenotype-driven plasma biobanking strategies and methods. J Pers Med 2015, 5:140-152.
14. May J.C., McLean J.A. Ion mobility-mass spectrometry: time-dispersive instrumentation. Anal Chem 2015, 87:1422-1436.
15. Woods A.S., Ugarov M., Egan T., Koomen J., Gillig K.J., Fuhrer K., Gonin M., Schultz J.A. Lipid/peptide/nucleotide separation with MALDI-ion mobility-TOFMS. Anal Chem 2004, 76:2187-2195.
16. Fenn L.S., McLean J.A. Biomolecular structural separations by ion mobility-mass spectrometry. Anal Bioanal Chem 2008, 391:905-909.
17. May J.C., Goodwin C.R., Lareau N.M., Leaptrot K.L., Morris C.B., Kurulugama R.T., Mordehai A., Klein C., Barry W., Darland E., Overney G., Imatani K., Stafford G.C., Fjeldsted J.C., McLean J.A. Conformational ordering of biomolecules in the gas-phase: nitrogen collision cross sections measured on a prototype high resolution drift tube ion mobility-mass spectrometer. Anal Chem 2014, 86:2107-2116.
18. Paglia G., Williams J.P., Menikarachchi L., Thompson J.W., Tyldesley-Worster R., Halldórsson S., Rolfsson O., Moseley A., Grant D., Langridge J., Palsson B.O., Astarita G. Ion mobility derived collision cross sections to support metabolomics applications. Anal Chem 2014, 86:3985-3993.
19. Paglia G., Angel P., Williams J.P., Richardson K., Olivos H.J., Thompson J.W., Menikarachchi L., Lai S., Walsh C., Moseley A., Plumb R.S., Grant D.F., Palsson B.O., Langridge J., Geromanos S., Astarita G. Ion mobility-derived collision cross section as an additional measure for lipid fingerprinting and identification. Anal Chem 2015, 87:1137-1144.
20. Hofmann J., Hahm H.S., Seeberger P.H., Pagel K. Identification of carbohydrate anomers using ion mobility-mass spectrometry. Nature 2015, 526:241-244.
21. Both P., Green A.P., Gray C.J., Sardzík R., Voglmeir J., Fontana C., Austeri M., Rejzek M., Richardson D., Field R.A., Widmalm G., Flitsch S.L., Eyers C.E. Discrimination of epimeric glycans and glycopeptides using IM-MS and its potential for carbohydrate sequencing. Nat Chem 2014, 6:65-74.
22. Gaye M.M., Kurulugama R., Clemmer D.E. Investigating carbohydrate isomers by IMS-CID-IMS-MS: precursor and fragment ion cross-sections. Analyst 2015, 140:6922-6932.
23. Li H., Bendiak B., Siems W.F., Gang D.R., Hill H.H. Determining the isomeric heterogeneity of neutral oligosaccharide-alditols of bovine submaxillary mucin using negative ion traveling wave ion mobility mass spectrometry. Anal Chem 2015, 87:2228-2235.
24. Struwe W.B., Benesch J.L., Harvey D.J., Pagel K. Collision cross sections of high-mannose N-glycans in commonly observed adduct states - identification of gas-phase conformers unique to [M-H](-) ions. Analyst 2015, 140:6799-6803.
25. Harvey D.J., Sobott F., Crispin M., Wrobel A., Bonomelli C., Vasiljevic S., Scanlan C.N., Scarff C.A., Thalassinos K., Scrivens J.H. Ion mobility mass spectrometry for extracting spectra of N-glycans directly from incubation mixtures following glycan release: application to glycans from engineered glycoforms of intact, folded HIV gp120. J Am Soc Mass Spectrom 2011, 22:568-581.
26. Kyle J.E., Zhang X., Weitz K.K., Monroe M.E., Ibrahim Y.M., Moore R.J., Cha J., Sun X., Lovelace E.S., Wagoner J., Polyak S.J., Metz T.O., Dey S.K., Smith R.D., Burnum-Johnson K.E., Baker E.S. Uncovering biologically significant lipid isomers with liquid chromatography, ion mobility spectrometry and mass spectrometry. Analyst 2016, 141:1649-1659. 10.1039/C5AN02062J.
27. Milic I., Kipping M., Hoffmann R., Fedorova M. Separation and characterization of oxidized isomeric lipid-peptide adducts by ion mobility mass spectrometry. J Mass Spectrom 2015, 50:1386-1392.
28. Zhang F., Guo S., Zhang M., Zhang Z., Guo Y. Characterizing ion mobility and collision cross section of fatty acids using electrospray ion mobility mass spectrometry. J Mass Spectrom 2015, 50:906-913.
29. Groessl M., Graf S., Knochenmuss R. High resolution ion mobility-mass spectrometry for separation and identification of isomeric lipids. Analyst 2015, 140:6904-6911.
30. Caprioli R.M. Imaging mass spectrometry: enabling a new age of discovery in biology and medicine through molecular microscopy. J Am Soc Mass Spectrom 2015, 26:850-852.
31. Heeren R.M., Smith D.F., Stauber J., Kükrer-Kaletas B., MacAleese L. Imaging mass spectrometry: hype or hope?. J Am Soc Mass Spectrom 2009, 20:1006-1014.
32. Trim P.J., Henson C.M., Avery J.L., McEwen A., Snel M.F., Claude E., Marshall P.S., West A., Princivalle A.P., Clench M.R. Matrix-assisted laser desorption/ionization-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. Anal Chem 2008, 80:8628-8634.
33. Cole L.M., Clench M.R. Mass spectrometry imaging tools in oncology. Biomark Med 2015, 9:863-868.
34. Spraggins J.M., Rizzo D.G., Moore J.L., Rose K.L., Hammer N.D., Skaar E.P., Caprioli R.M. MALDI FTICR IMS of intact proteins: using mass accuracy to link protein images with proteomics data. J Am Soc Mass Spectrom 2015, 26:974-985.
35. McLean J.A., Ridenour W.B., Caprioli R.M. Profiling and imaging of tissues by imaging ion mobility-mass spectrometry. J Mass Spectrom 2007, 42:1099-1105.
36. Jackson S.N., Ugarov M., Egan T., Post J.D., Langlais D., Albert Schultz J., Woods A.S. MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue. J Mass Spectrom 2007, 42:1093-1098.
37. Bennett R.V., Gamage C.M., Galhena A.S., Fernández F.M. Contrast-enhanced differential mobility-desorption electrospray ionization-mass spectrometry imaging of biological tissues. Anal Chem 2014, 86:3756-3763.
38. Jackson S.N., Barbacci D., Egan T., Lewis E.K., Schultz J.A., Woods A.S. MALDI-ion mobility mass spectrometry of lipids in negative ion mode. Anal Methods 2014, 6:5001-5007.
39. Matusch A., Fenn L.S., Depboylu C., Klietz M., Strohmer S., McLean J.A., Becker J.S. Combined elemental and biomolecular mass spectrometry imaging for probing the inventory of tissue at a micrometer scale. Anal Chem 2012, 84:3170-3178.
40. Djidja M.C., Claude E., Snel M.F., Scriven P., Francese S., Carolan V., Clench M.R. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections. J Proteome Res 2009, 8:4876-4884.
41. Stauber J., MacAleese L., Franck J., Claude E., Snel M., Kaletas B.K., Wiel I.M., Wisztorski M., Fournier I., Heeren R.M. On-tissue protein identification and imaging by MALDI-ion mobility mass spectrometry. J Am Soc Mass Spectrom 2010, 21:338-347.
42. Baker E.S., Burnum-Johnson K.E., Jacobs J.M., Diamond D.L., Brown R.N., Ibrahim Y.M., Orton D.J., Piehowski P.D., Purdy D.E., Moore R.J., Danielson W.F., Monroe M.E., Crowell K.L., Slysz G.W., Gritsenko M.A., Sandoval J.D., LaMarche B.L., Matzke M.M., Webb-Robertson B.J., Simons B.C., McMahon B.J., Bhattacharya R., Perkins J.D., Carithers R.L., Strom S., Self S.G., Katze M.G., Anderson G.A., Smith R.D. Advancing the high throughput identification of liver fibrosis protein signatures using multiplexed ion mobility spectrometry. Mol Cell Proteomics 2014, 13:1119-1127.
43. Marasco C.C., Enders J.R., Seale K.T., McLean J.A., Wikswo J.P. Real-time cellular exometabolome analysis with a microfluidic-mass spectrometry platform. PLOS ONE 2015, 10:e0117685.
44. Shi M., Majumdar D., Gao Y., Brewer B.M., Goodwin C.R., McLean J.A., Li D., Webb D.J. Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts. Lab Chip 2013, 13:3008-3021.
45. Sherrod S.D., McLean J.A. Systems-wide high-dimensional data acquisition and informatics using structural mass spectrometry strategies. Clin Chem 2016, 62:77-83.
46. May J.C., McLean J.A. Advanced multidimensional separations in mass spectrometry: navigating the big data deluge. Annu Rev Anal Chem 2016, 10.1146/annrev-anchem-071015-041734.
47. Ivanisevic J., Elias D., Deguchi H., Averell P.M., Kurczy M., Johnson C.H., Tautenhahn R., Zhu Z., Watrous J., Jain M., Griffin J., Patti G.J., Siuzdak G. Arteriovenous blood metabolomics: a readout of intra-tissue metabostasis. Sci Rep 2015, 12757.
48. Goodwin C.R., Sherrod S.D., Marasco C.C., Bachmann B.O., Schramm-Sapyta N., Wikswo J.P., McLean J.A. Phenotypic mapping of metabolic profiles using self-organizing maps of high-dimensional mass spectrometry data. Anal Chem 2014, 86:6563-6571.
49. Derewacz D.K., Covington B.C., McLean J.A., Bachmann B.O. Mapping microbial response metabolomes for induced natural product discovery. ACS Chem Biol 2015, 10:1998-2006.
50. Goodwin C.R., Covington B.C., Derewacz D.K., McNees C.R., Wikswo J.P., McLean J.A., Bachmann B.O. Structuring microbial metabolic responses to multiplexed stimuli via self-organizing metabolomics maps. Chem Biol 2015, 22:661-670.
51. Kumar K.K., Goodwin C.R., Uhouse M.A., Bornhorst J., Schwerdtle T., Aschner M., McLean J.A., Bowman A.B. Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. Metallomics 2015, 7:363-370.
52. Li S., Park Y., Duraisingham S., Strobel F.H., Khan N., Soltow Q.A., Jones D.P., Pulendran B. Predicting network activity from high throughput metabolomics. PLoS Comput Biol 2013, 9:e1003123.